Skip to content

Catalent biologics contracting still big growth driver

May 5, 2017

Catalent Inc. ( CTLT ) reported third quarter adjusted EPS of $0.38 after the bell Thursday, up from $0.21 in the prior year period.

Catalent has spiked to the upside in early trade Friday and is currently higher by 3.97 at $32.90 on above average volume. The stock has surged past resistance and has set a new high for the year.

http://bit.ly/2qLMTUS

Advertisements

From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: